Loss of Consciousness and Visual Hallucinations Related to 5-MeO-DALT Intake, a Case Report Confirmed by Toxicological Analyses.
Laurène Dufayet, Jérôme Langrand, Jean-Claude Alvarez, Amine Islam Larabi
Journal of Analytical Toxicology August 13, 2022 DOI: 10.1093/jat/bkac021 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | A 46-year-old man |
| Intervention | 5-MeO-DALT |
| Dose | three 5-MeO-DALT tablets (32.5 mg per tablet, 11% purity) |
| Topics | 5-MeO-DMT |
| Citations | 3 |
| Key findings | Ingestion of 5-MeO-DALT tablets caused brief loss of consciousness and visual hallucinations, and the drug was quantified in the tablets and patient's plasma. |
Abstract
5-MeO-DALT or 5-methoxy-N,N-diallyltryptamine is a derivative of tryptamines, consumed for its hallucinogenic and entheogenic effects. We report the case of a 46-year-old-man, presenting with a brief loss of consciousness and visual hallucinations, after the consumption of three 5-MeO-DALT tablets bought online. Liquid chromatography coupled to tandem mass spectrometry method was performed, and 5-MeO-DALT was quantified in both the tablets (32.5 mg per tablet, 11% of purity) and the patient's plasma (7 ng/mL-8 h between the consumption and the blood sample). 5-MeO-DALT poisonings are rarely described. Given the broad availability of these products, it is important that emergency department physicians and clinical toxicologists do not overlook the possibility of the ingestion of recreational tryptamines, especially since they are not detected by most routine toxicological screening.